Funding Opportunities

NIH Funding Opportunities

NCCIH Policy for Submission of R21 Applications Containing Clinical Trials
Notice NOT-AT-15-004 from the NIH Guide for Grants and Contracts
Fri, 06 Mar 2015 01:51:44 EST

Notice of Clarification of Application Instructions in PAR-14-240 "Collaborative Research Projects to Enhance Applicability of Mouse Models for Translational Research (Collaborative R01)"
Notice NOT-CA-15-016 from the NIH Guide for Grants and Contracts
Wed, 04 Mar 2015 12:37:58 EST

Notice of Clarification for RFA-DA-15-014 Adolescent Brain Cognitive Development (ABCD) Study - Coordinating Center (U24)
Notice NOT-DA-15-051 from the NIH Guide for Grants and Contracts
Wed, 04 Mar 2015 12:33:31 EST

Notice of Expiration of PAR-13-367 "Planning Grants for Pragmatic Research in Healthcare Settings to Improve Diabetes Prevention and Care (R34)"
Notice NOT-DK-15-008 from the NIH Guide for Grants and Contracts
Fri, 06 Mar 2015 01:33:15 EST

Notice of Expiration of PAR-13-366 "Pragmatic Research in Healthcare Settings to Improve Diabetes Prevention and Care (R18)"
Notice NOT-DK-15-009 from the NIH Guide for Grants and Contracts
Wed, 04 Mar 2015 12:44:16 EST

Notice of Change in Next Submission Due Date to NIEHS for Diversity and Regular Administrative Supplements
Notice NOT-ES-15-014 from the NIH Guide for Grants and Contracts
Fri, 06 Mar 2015 01:24:13 EST

AHRQ Announces Continued Interest in Career Development and Dissertation Awards
Notice NOT-HS-15-007 from the NIH Guide for Grants and Contracts
Wed, 04 Mar 2015 12:39:07 EST

Notice of Correction to PA-15-087 "Development of Novel and Emerging Technologies to Support Zebrafish Models for Biomedical Research (R41/R42)"
Notice NOT-OD-15-074 from the NIH Guide for Grants and Contracts
Wed, 04 Mar 2015 12:01:52 EST

Notice of Correction to PA-15-086 "Development of Novel and Emerging Technologies to Support Zebrafish Models for Biomedical Research (R43/R44)"
Notice NOT-OD-15-075 from the NIH Guide for Grants and Contracts
Wed, 04 Mar 2015 12:06:11 EST

Eye on NIH Policy: OMB Uniform Guidance - What it Means for NIH and You (Video and Interactive Q and A - March 12, 2015)
Notice NOT-OD-15-077 from the NIH Guide for Grants and Contracts
Fri, 06 Mar 2015 02:40:57 EST

Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7)
Funding Opportunity RFA-AI-15-009 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to continue to provide operations support under the UC7 mechanism for Biosafety Level 4 (BSL4) facilities at the National Biocontainment Laboratories at the University of Texas Medical Branch (UTMB) in Galveston, Texas and Boston University in Boston, Massachusetts.Operations support is provided in the following areas: facility maintenance and operations; biosecurity; environmental health and safety regulations and requirements; regulatory compliance; and specialized research support services.The NBLs will serve as a national resource for efforts in conducting clinical and laboratory (in vitro and in vivo) research and testing on hazardous biological agents in support of NIAIDs Biodefense Research Agenda (http://www3.niaid.nih.gov/topics/BiodefenseRelated/Biodefense/about/strategicplan.htm) and other infectious diseases.
Fri, 06 Mar 2015 02:37:49 EST

Validation of Pediatric Patient Reported Outcomes in Chronic Diseases (PEPR) Consortium (U19)
Funding Opportunity RFA-AR-15-014 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to solicit applications for the Validation of Pediatric Patient Reported Outcomes in Chronic Diseases (PEPR) Consortium. The NIAMS, on behalf of the National Institutes of Health, intends to capitalize on recent advances in the science of Patient Reported Outcomes (PROs) to measure the patient experience in clinical care and research in children with a variety of chronic diseases and conditions (e.g., asthma, juvenile arthritis, cystic fibrosis, diabetes, obesity and overweight, chronic kidney disease, inflammatory bowel disease, sickle cell disease, malnutrition, developmental disabilities including attention deficit/hyperactivity disorder and autism spectrum disorder, cerebral palsy and mental illnesses) using the Patient-Reported Outcomes Measurement Information System (PROMIS) tools and approaches coupled with detailed clinical phenotyping and/or biospecimen collection in well-characterized human cohorts. The Patient Reported Outcomes Measurement Information System (PROMIS) is a system of highly reliable, precise measures of patientreported health status for physical, mental, and social wellbeing. PROMIS tools measure what patients are able to do and how they feel by asking questions. PROMIS measures can be used as primary or secondary endpoints in clinical studies of the effectiveness of treatment.
Fri, 06 Mar 2015 08:49:37 EST

Biological and Physiological Effects of E-cigarette Aerosol Mixtures (R01)
Funding Opportunity RFA-DE-16-004 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support research aimed at understanding the biological and physiological effects of aerosol mixtures produced by electronic cigarettes (ECs) on cells, tissues and organs of the oral cavity including oral and periodontal epithelia, gingiva, salivary glands, and tooth. This FOA will also support research on elucidation of the effects of ECs on oral microbiome. Research supported by this FOA would provide essential and necessary information on the biological effects of ECs that would in turn lead to evidence based foundational information for health policy decisions.
Thu, 05 Mar 2015 01:28:17 EST

Biological and Physiological Effects of E-cigarette Aerosol Mixtures (R21)
Funding Opportunity RFA-DE-16-005 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support research aimed at understanding the biological and physiological effects of aerosol mixtures produced by electronic cigarettes (ECs) on cells, tissues and organs of the oral cavity including oral and periodontal epithelia, gingiva, salivary glands, and tooth. This FOA will also support research on elucidation of the effects of ECs on oral microbiome. Research supported by this FOA would provide essential and necessary information on the biological effects of ECs that would in turn lead to evidence based foundational information for health policy decisions.
Thu, 05 Mar 2015 01:28:03 EST

Mobilizing Research: A Research Resource to Enhance mHealth Research (U2C)
Funding Opportunity RFA-OD-15-129 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support the development of Mobilizing Research a research resource that would allow researchers to more efficiently and rapidly evaluate mobile and wireless (mHealth) technologies. This research resource is intended to develop an infrastructure that works with wireless carriers to create a registry of potential participants to facilitate mHealth research across a variety of observational and clinical research studies and settings, and for a range of diseases and populations. This FOA supports Mobilizing Research for development of the infrastructure and transition to sustainability. Therefore, the proposed integrated and centralized resource should be designed and operated in a way that will facilitate and enable its sustainable functioning in the near future.
Mon, 02 Mar 2015 02:04:55 EST

NEI Administrative Supplements to Small Business Innovative Research (SBIR) Grants for the Procurement of Expertise in the Federal Regulatory Approval Process for New Drugs and/or Devices (Admin Supp)
Funding Opportunity PA-15-132 from the NIH Guide for Grants and Contracts. NEI announces an Administrative Supplement opportunity available to eligible NEI awardees with active SBIR Phase I/II grants. These administrative supplements provide funds so that grantees can procure the services of consultants who are knowledgeable in the Federal regulatory process for approval of new drugs and/or devices. The purpose of these administrative supplements is to allow Small Business grantees to bring innovative vision and eye care products to the marketplace more efficiently.
Thu, 05 Mar 2015 01:33:48 EST

Functional Wellness in HIV: Maximizing the Treatment Cascade (R01)
Funding Opportunity PA-15-133 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) seeks to promote the development of HIV interventions which target opportunities to improve the delivery of healthcare across the continuum of care for persons infected with HIV.
Thu, 05 Mar 2015 12:57:14 EST

Functional Wellness in HIV: Maximizing the Treatment Cascade (R21)
Funding Opportunity PA-15-134 from the NIH Guide for Grants and Contracts. The National Institute of Nursing Research (NINR) seeks to promote the development of HIV interventions which target opportunities to improve the delivery of healthcare across the continuum of care for persons infected with HIV.
Thu, 05 Mar 2015 12:56:56 EST

Investigations on Primary Immunodeficiency Diseases (R01)
Funding Opportunity PAR-15-130 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is intended to support innovative investigations in primary immunodeficiency diseases.Of particular interest are the detection of primary immunodeficiency diseases, the identification of the molecular basis of these diseases, and the design and pre-clinical development of innovative therapies for these diseases.
Wed, 04 Mar 2015 12:30:01 EST

Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11)
Funding Opportunity PAR-15-131 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications from research institutions in low- to middle-income countries (LMIC) to provide senior administrators from these institutions with advanced training in the management of NIH grants. The ultimate goal is to improve oversight of NIAID grant awards and compliance with NIH funding policies and Federal research funding requirements for NIAID-supported foreign institutions in low to middle-income countries.
Wed, 04 Mar 2015 05:16:53 EST